Synergistic Induction of Apoptosis and Cell Cycle Arrest against Breast Cancer Cells by Combined Kaempferol and Paclitaxel

Abstract

Background

The study investigates the potential of combining Kaempferol (KAE) and Paclitaxel (PAC) to enhance anti-cancer effects and induce apoptosis in MDA-MB-468 triple-negative breast cancer cells and human normal foreskin fibroblast cells.

Methods

For this porpose, the cells were treated with PAC, KAE, and their combination for 24, 48, and 72 hours. Cytotoxicity was assessed via MTT assay, and synergy was evaluated using Combination Index analysis. Apoptosis was quantified via Annexin V/PI staining and DAPI staining. Flow cytometry analyzed cell cycle arrest, while qPCR assessed apoptotic gene expression.

Results

The combination of KAE and PAC exhibited a synergistic anti-proliferative effect, significantly reducing MDA-MB-468 cell viability compared to monotherapies. Annexin V/PI staining revealed an increased apoptotic rate (73%) in co-treated cells, with enhanced chromatin condensation and nuclear fragmentation observed via DAPI staining. Flow cytometry indicated a marked increase in SubG1 phase cells, confirming apoptosis induction. Gene expression analysis demonstrated upregulation of pro-apoptotic BAD and downregulation of anti-apoptotic Bcl-2 and Mcl-1, highlighting the activation of apoptosis pathways.

Conclusion

The combination of PAC and KAE enhances cytotoxicity, promotes apoptosis, and alters key apoptotic gene expressions in MDA-MB-468 cells while sparing normal fibroblast cells. These findings suggest a promising therapeutic strategy for triple-negative breast cancer.

Keywords

kaempferol - paclitaxel - combination therapy - apoptosis - cell cycle arrest

Publication History

Received: 14 December 2024

Accepted: 13 June 2025

Article published online:
14 July 2025

• References

• 1 Xue L, Pilehvar Y, Afshari H. et al. Radiosensitization of breast cancer cells with AgBiS2 nanodots: Preparation and in vitro evaluations. Applied Organometallic Chemistry 2024; 38: e7638
• 2 Talaei S, Mellatyar H, Pilehvar-Soltanahmadi Y. et al. 17-Allylamino-17-demethoxygeldanamycin loaded PCL/PEG nanofibrous scaffold for effective growth inhibition of T47D breast cancer cells. Journal of Drug Delivery Science and Technology 2019; 49: 162-168
• 3 Azamjah N, Soltan-Zadeh Y, Zayeri F. Global trend of breast cancer mortality rate: a 25-year study. Asian Pacific journal of cancer prevention: APJCP 2019; 20: 2015
• 4 Uscanga-Perales GI, Santuario-Facio SK, Ortiz-López R. Triple negative breast cancer: Deciphering the biology and heterogeneity. Medicina universitaria 2016; 18: 105-114
• 5 Cella D, Peterman A, Hudgens S. et al. Measuring the side effects of taxane therapy in oncology: The Functional Assessment of Cancer Therapy–taxane (FACT-taxane). Cancer: Interdisciplinary International Journal of the American Cancer Society 2003; 98: 822-831
• 6 Čermák V, Dostál V, Jelínek M. et al. Microtubule-targeting agents and their impact on cancer treatment. European journal of cell biology 2020; 99: 151075
• 7 Ge X, Zhang D, Song S. et al. USP18 reduces paclitaxol sensitivity of triple-negative breast cancer via autophagy. Biochemical and Biophysical Research Communications 2022; 599: 120-126
• 8 Meng J, Guo F, Xu H. et al. Combination therapy using co-encapsulated resveratrol and paclitaxel in liposomes for drug resistance reversal in breast cancer cells in vivo. Scientific reports 2016; 6: 22390
• 9 Gao Q, Feng J, Liu W. et al. Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment. Advanced Drug Delivery Reviews 2022; 188: 114445
• 10 Dadashpour M, Pilehvar-Soltanahmadi Y, Zarghami N. et al. Emerging importance of phytochemicals in regulation of stem cells fate via signaling pathways. Phytotherapy Research 2017; 31: 1651-1668
• 11 Chatran M, Pilehvar-Soltanahmadi Y, Dadashpour M. et al. Synergistic anti-proliferative effects of metformin and silibinin combination on T47D breast cancer cells via hTERT and cyclin D1 inhibition. Drug research 2018; 68: 710-716
• 12 Shahbaz M, Imran M, Alsagaby SA. et al. Anticancer, antioxidant, ameliorative and therapeutic properties of kaempferol. International Journal of Food Properties 2023; 26: 1140-1166
• 13 Bangar SP, Chaudhary V, Sharma N. et al. Kaempferol: A flavonoid with wider biological activities and its applications. Critical Reviews in Food science and nutrition 2023; 63: 9580-9604
• 14 Sengupta B, Biswas P, Roy D. et al. Anticancer properties of kaempferol on cellular signaling pathways. Current topics in medicinal chemistry 2022; 22: 2474
• 15 Aghazadeh T, Bakhtiari N, Rad IA. et al. Formulation of kaempferol in nanostructured lipid carriers (NLCs): a delivery platform to sensitization of MDA-MB468 breast cancer cells to paclitaxel. Biointerface Res Appl Chem 2021; 11: 14591-14601
• 16 Kaur S, Mendonca P, Soliman KF. The Anticancer Effects and Therapeutic Potential of Kaempferol in Triple-Negative Breast Cancer. Nutrients 2024; 16: 2392
• 17 Asnaashari S, Amjad E, Sokouti B. Synergistic effects of flavonoids and paclitaxel in cancer treatment: a systematic review. Cancer cell international 2023; 23: 211
• 18 Afzal M, Alarifi A, Karami AM. et al. Antiproliferative mechanisms of a polyphenolic combination of kaempferol and fisetin in triple-negative breast cancer cells. International Journal of Molecular Sciences 2023; 24: 6393
• 19 Fang Y, Cao W, Xia M. et al. Transport and interactions of co-incubated bi-functional flavonoids through inhibiting the function of P-glycoprotein (P-gp) using KB/multidrug-resistant (MDR) cells and rat everted gut sacs. Journal of Agricultural and Food Chemistry 2022; 70: 1923-1933
• 20 Nandi SK, Roychowdhury T, Chattopadhyay S. et al. Deregulation of the CD44-NANOG-MDR1 associated chemoresistance pathways of breast cancer stem cells potentiates the anti-cancer effect of Kaempferol in synergism with Verapamil. Toxicology and Applied Pharmacology 2022; 437: 115887
• 21 Zhou Q, Fang G, Pang Y. et al. Combination of kaempferol and docetaxel induces autophagy in prostate cancer cells in vitro and in vivo. International Journal of Molecular Sciences 2023; 24: 14519
• 22 Priyamvada P, Ashok G, Joshi T. et al. Unravelling the molecular mechanistic pathway underlying the anticancer effects of kaempferol in colorectal cancer: a reverse pharmacology network approach. Molecular Diversity 2025; 29: 1049-1067
• 23 Hon KW, Naidu R. Synergistic Mechanisms of Selected Polyphenols in Overcoming Chemoresistance and Enhancing Chemosensitivity in Colorectal Cancer. Antioxidants 2024; 13: 815
• 24 Wang X, Yang Y, An Y. et al. The mechanism of anticancer action and potential clinical use of kaempferol in the treatment of breast cancer. Biomedicine & Pharmacotherapy 2019; 117: 109086